botulinum

Highly concentrated botulinum preparation for cosmetic injections can result in severe illness

An examination of 4 cases of botulism following cosmetic injections to the face indicates that the adults received a highly concentrated, unlicensed preparation that resulted in toxin levels up to 40 times the estimated human lethal dose, according to a report in the November 22/29 issue of JAMA. Botulism is a rare paralytic illness caused by the toxins of the spore-forming bacterium Clos...

Molecular structure reveals how botulinum toxin attaches to nerve cells

WHAT: Botulism is a life-threatening disease caused by exposure to botulinum neurotoxins, which are among the most potent toxins known. These neurotoxins are produced by Clostridium botulinum, a bacterium found in soil and food. In the body, the toxins bind to and enter neurons, interfering with nerve transmission and disrupting the communication between the nerve and muscle fibers throughout the...

Genome of Clostridium botulinum reveals the background to world's deadliest toxin

The genome sequence sho...

botulinum at Biology Products

Chicken Anti-Ras-related C3 botulinum toxin substrate 1 Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.

Description:Ras-related C3 botulinum toxin substrate 1...
Company:GenWay Biotech, Inc.

botulinum at Biology Technology

Clostridium botulinum

Clostridium botulinum...

Clostridium botulinum

Clostridium botulinum...

Mentor Licenses Botulinum From WARF and Plans Wisconsin Manufacturing Facility

MADISON, Wis. - The a California-based publicly traded company (NYSE: MNT), which gives Mentor the exclusive manufacturing and marketing rights to the proprietary botulinum...

botulinum at Medicine News

Appearance Of Facial Scars Improved By Botulinum Toxin

Researchers from Mayo Clinic have reported improved appearance of scars following injection with botulinum toxin (BOTOX?) early after// the occurrence of a wound. The injection prevents muscle movement from wrinkling the wound site by paralyzing the region thus creating a smooth surface for healing and leaving a smoother final scar.The researchers have found that treating a facial...

Highly-Concentrated Botulinum Preparation Can Result in Severe Illness

An examination of 4 cases of botulism following cosmetic injections to the face indicates that the adults received a highly concentrated, //unlicensed preparation that resulted in toxin levels up to 40 times the estimated human lethal dose, according to a report. Botulism is a rare paralytic illness caused by the toxins of the spore-forming bacterium Clostridium botulinum and toxin-pro...

Uses for Botulinum Toxin — A Miracle Poison — Continue to Grw

First, it was infamous as a deadly form of food poison. Then, fame came as a temporary remedy for wrinkles. Now, botulinum toxin is considered the 'miracle poison' and used for an increasing number of medical conditions. // The December issue of Mayo Clinic Health Letter covers how this drug works and its multiple and emerging applications. Botulinum toxin blocks communic...

botulinum at Medicine Products

BOTOX® Cosmetic Botulinum Toxin Type A

Description:BOTOX® Cosmetic is a simple, nonsurgical, physician-administered treatment that can temporarily smooth moderate to severe frown lines between the brows in people from 18 to 65 years of age. It is the only treatment of its type approved by the Food and Drug Administration (FDA). BOTOX® Cosmetic is a purified protein produced by the Clostridium botulinum bacterium, which reduces the acti...
Company:Allergan, Inc.

Myobloc®(Botulinum Toxin Type B) Injectable Solution

Description:Myobloc (Botulinum Toxin Type B) Injectable Solution, the only Botulinum Toxin Type B treatment available, has been demonstrated in numerous published studies to be safe and effective in treating cervical dystonia. Delivered as a purified, ready-to-use solution, in three convenient vial sizes, Myobloc offers a simpler way to significantly reduce abnormal head position and neck pain associated...
Company:Solstice Neurosciences, Inc.

Dysport® Clostridium Botulinum Type A

Description:Dysport is a simple, effective, non-surgical treatment that works by relaxing facial muscles on the forehead, thereby reducing and smoothing away frown-lines and wrinkles. Dysport is supported by over a decade of clinical experience. Dysport was developed in the United Kingdom in the early 1990s to successfully treat a number of neurological and ophthalmic conditions. Since that time, with an...
Company:New Zealand Medical and Scientific Ltd

Clostridium botulinum Culture

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

botulinum at Medicine Technology

DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC

MIAMI, FL -- (MARKET WIRE) -- July 06, 2007 -- DOR BioPharma,Inc. (OTCBB: <a target="_blank" href='http://studio.financialcontent.com/Engine?Account=iwire&PageName=QUOTE&Ticker=DORB"%3EDORB'>http://studio.financialcontent.com/Engine?Account=iwire&PageName=QUOTE&Ticker=DORB">DORB )("DOR" or the "Company") announced today that the European PatentOffice has granted a paten...

DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC

MIAMI--(MARKET WIRE) -- July 02, 2007 -- DOR BioPharma, Inc.(OTCBB: DORB) ("DOR" or the "Company") announced today that thefirst results from testing of a multivalent form of its botulinumtoxin vaccine, BT-VACC™, have been published in the journalInfection and Immunity (Ravichandran et al., 2007, Infection andImmunity, v. 75, p. 3043 ). These results are the first thatdescribe the...

First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A) Significantly Improves Idiopathic Detrusor Overactivity (IDO) in Patients With Symptoms of Overactive Bladder

Treatment Benefits Were Maintained for at Least 24 Weeks, Accordingto Report Published in The Journal of Urology LONDON, May 15, 2007 /PRNewswire/ -- Researchers from Guy'sHospital and King's College London School of Medicine haveannounced the results from the first randomized, double-blind,placebo-controlled study evaluating botulinum toxin type A (BTX-A,BOTOX(R)) as a treatment for idio...